eli lilly retatrutide trial sign up Lilly's Phase 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Clinical trial results for retatrutide,

Regular follow-up with your doctor ensures safe and sustainable progress

4 Of all healthcare jobs, obesity rates were significantly higher with nurses compared to doctors, paramedics, technicians, and other medical roles

In simpler terms, in this older, highcardiovascular-risk crowd, those who ate the most lycopene-rich foods were substantially less likely to hear the words you have prostate cancer during the study period

While most people taking GLP-1s deal with daily discomfort rather than emergencies, Carroll says that there are some serious complications worth knowing about, including acute pancreatitis, gallbladder disease, and severe dehydration from prolonged vomiting or diarrhea